HILLSBORO, Ore., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Shorepower Technologies, Inc. (OTC: SPEV) ("Shorepower" or the "Company") today announced that it has entered into an Agreement and Plan of Merger dated February 17, 2026, with Aeternum Health LLC ("Aeternum Health"), pursuant to which Aeternum Health will merge with and into Shorepower, with Shorepower continuing as the surviving entity.Upon completion of the merger, the Company intends to transition its strategic focus from transportation electrification ...

Group 1 - The core viewpoint of the report emphasizes the potential of Novartis' Pluvicto in the nuclear medicine sector, particularly in the context of Radioligand Therapy (RDC), which is expected to drive growth in the nuclear medicine industry [4][15][26] - The report highlights that the nuclear medicine market in China is projected to reach 26 billion yuan by 2030, with significant growth potential driven by policy support and technological advancements [16][20] - The report identifies key companies to watch, including Dongcheng Pharmaceutical, which has a leading integrated drug innovation platform, and ASP Isotopes Inc., which focuses on high-value isotope production [4][32][37] Group 2 - The report provides a market review for the week of January 19-23, 2026, noting that the CITIC Pharmaceutical Index fell by 0.4%, while the pharmaceutical sector has seen a year-to-date increase of 6.5% [3][40] - The report indicates that the top-performing stocks in the pharmaceutical sector during this week included Changyao Holdings (+70.4%) and Hualan Biological Engineering (+32.2%) [5][55] - The report discusses the performance of various sub-sectors within the pharmaceutical industry, with pharmaceutical distribution and retail showing positive trends, while innovative drugs and CXO sectors lagged [5][43][66]

Core Viewpoint - ASP Isotopes (ASPI) stock experienced a significant increase following the acquisition of Renergen Limited, marking a crucial step in the company's growth strategy [1] Group 1: Acquisition Impact - The merger combines ASPI's advanced enrichment technology with Renergen's helium and natural gas production assets, particularly enhancing the Virginia Gas Project in South Africa [1] - This acquisition positions ASPI to tap into high-growth markets such as semiconductors, quantum computing, and clean energy applications, transitioning the company from a pure enrichment tech firm to an integrated producer with revenue-generating operations [3] Group 2: Financial Aspects - The transaction is supported by approximately $750 million in committed debt financing from the U.S. International Development Finance Corporation, providing significant capital for helium production expansion without immediate equity dilution [4] - This non-dilutive funding indicates strong governmental backing and confidence in the project's viability, offering operational flexibility for accelerated production while preserving shareholder stakes [5] Group 3: Market Position and Technical Analysis - The timing of the Renergen deal aligns with heightened geopolitical focus on domestic production of critical materials, which may foster favorable regulatory and trade policy environments [6] - From a technical perspective, ASPI stock is approaching a major resistance level at $7.87, and a decisive break above this point could enhance bullish momentum in the near term [6] Group 4: Analyst Sentiment - Currently, ASPI shares are rated as "Strong Buy" by the only two Wall Street analysts covering the stock, indicating positive sentiment among market experts [7]

Company Overview - ASP Isotopes Inc. (ASPI) has successfully closed its acquisition of Renergen Limited, which enhances its capabilities in isotope enrichment and expands its portfolio in the energy sector [1][3]. - The merger combines ASP Isotopes' advanced enrichment technologies with Renergen's helium and natural gas assets, particularly the Virginia Gas Project in South Africa [1][2]. Strategic Goals - The combined entity aims to become a leading global supplier of critical materials for high-growth sectors such as semiconductors, quantum computing, and clean energy [2]. - A significant aspect of the deal is Renergen's access to approximately $750 million in committed debt funding from the U.S. International Development Finance Corporation (DFC) to boost helium production capacity [2]. Market Position - ASP Isotopes does not directly mine rare earth elements but focuses on the production and enrichment of stable isotopes that are part of the broader strategic materials universe, including elements related to rare earths [3].

Core Insights - U.S. stocks experienced an upward trend, with the Dow Jones index increasing by approximately 200 points on Friday [1] Company Highlights - CG Oncology Inc (NASDAQ:CGON) saw its shares rise by 21.8% to $51.05 after announcing an expedited timeline for topline data from the Phase 3 PIVOT-006 clinical trial, now expected in the first half of 2026 [1][2] - Rich Sparkle Holdings Ltd (NASDAQ:ANPA) surged 113.6% to $51.70 following a $39 million offering of 3 million ordinary shares at $13 per share [3] - NovaBay Pharmaceuticals Inc (NYSE:NBY) increased by 34.4% to $12.81 [3] - Quanterix Corp (NASDAQ:QTRX) gained 29.3% to $8.42 after naming Everett Cunningham as President and CEO, effective January 19 [3] - MoonLake Immunotherapeutics (NASDAQ:MLTX) rose 21.7% to $17.45 after receiving FDA feedback on its clinical evidence strategy for Sonelokimab in Hidradenitis Suppurativa [3] - Enliven Therapeutics Inc (NASDAQ:ELVN) increased by 21.5% to $28.24, sharing positive initial data from its Phase 1b ENABLE trial for ELVN-001 in chronic myeloid leukemia [3] - Aeva Technologies Inc (NASDAQ:AEVA) surged 21.2% to $20.47 [3] - Loandepot Inc (NYSE:LDI) rose 20.1% to $2.93 [3] - ASP Isotopes Inc (NASDAQ:ASPI) increased by 19.7% to $7.71 [3] - Allogene Therapeutics Inc (NASDAQ:ALLO) gained 19.5% to $1.78 [3] - Opendoor Technologies Inc (NASDAQ:OPEN) rose 19.2% to $7.67 following a new housing market proposal by President Donald Trump [3] - Liquidia Corp (NASDAQ:LQDA) jumped 14% to $36.22 after announcing preliminary full-year 2025 YUTREPIA net sales [3] - Vistra Corp (NYSE:VST) gained 13.1% to $170.34 after entering into 20-year power purchase agreements for zero-carbon nuclear energy to support Meta's operations [3] - Oklo Inc (NYSE:OKLO) rose 12.6% to $109.95 after announcing an agreement with Meta for a 1.2 gigawatt power campus [3] - Applied Digital Corp (NASDAQ:APLD) surged 11.8% to $35.72, reporting strong second-quarter results and advanced talks with a new hyperscaler tenant [3] - AST SpaceMobile Inc (NASDAQ:ASTS) gained 10% to $99.65 [3] - SanDisk Corp (NASDAQ:SNDK) increased by 9.6% to $366.93 [3] - Mirion Technologies Inc (NYSE:MIR) rose 9.5% to $26.56 [3] - TTM Technologies Inc (NASDAQ:TTMI) gained 9.1% to $72.94 [3] - SoundHound AI Inc (NASDAQ:SOUN) rose 8.5% to $11.96 [3] - Kratos Defense & Security Solutions Inc (NASDAQ:KTOS) gained 8.3% to $112.64, with B. Riley Securities maintaining a Buy rating and raising the price target from $105 to $128 [3]

Industry Overview - Nuclear energy is transitioning from being viewed as the "black sheep" of the power sector to the "gold standard" for clean energy due to increasing electricity demands from AI data centers and electric vehicles [1] - Unlike solar and wind energy, nuclear energy provides reliable "baseload" power, operating continuously and emitting zero carbon [2] Company Focus: ASP Isotopes (ASPI) - ASP Isotopes (ASPI) is identified as a high-risk, high-reward investment opportunity, focusing on the enrichment process of uranium fuel [2] - The company employs a proprietary method called Aerodynamic Separation for uranium enrichment, which is efficient and cost-effective [3] - ASPI is positioning itself as a primary supplier of High-Assay Low-Enriched Uranium (HALEU), essential for next-generation small modular reactors (SMRs), amid a global shortage [4] Financial Position and Growth - ASP recently raised over $72 million to establish an enrichment facility in South Africa and acquired Renergen Limited, diversifying into helium production for a more stable revenue stream [5] - In the first nine months of 2025, ASP reported a loss of nearly $100 million, ending Q3 with $113 million in cash, indicating a potential need for additional capital [5] - Analysts have a "Strong Buy" recommendation for ASPI, with a mean stock price target of $12, significantly above the current price of $6.31 [6]

Company Performance - ASP Isotopes Inc. (NASDAQ:ISP) experienced a decline of 5.08% on Tuesday, closing at $5.42, marking its third consecutive day of losses as investors reacted to a significant stake sale by a key executive [1][3] - The chief finance officer, Heather Kiessling, disposed of 80,000 shares at a weighted average price of $5.798 on December 18, leaving her with 732,500 shares [2][3] Acquisition Details - ASP Isotopes has received all regulatory approvals for its planned acquisition of Renergen Ltd. in an all-stock deal, which is expected to enhance its market position [3] - Under the acquisition agreement, ASP Isotopes will pay Renergen shareholders 0.09196 new ASP Isotopes shares for each unit they own [4] - The merger aims to create a global leader in the production of critical materials, including electronic gases like helium and various fluorinated products [5]

As filed with the Securities and Exchange Commission on December 23, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Illumination Acquisition Corp I (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Illumin ...

Core Insights - U.S. stocks experienced a decline, with the Dow Jones falling approximately 0.1% on Thursday [1] - Donaldson Company, Inc. saw a significant increase in its stock price following positive quarterly results [1] Financial Performance - Donaldson's sales increased by 3.9% year over year to $935.4 million, surpassing the consensus estimate of $922.9 million, driven by favorable currency translation and volume growth [2] - GAAP net earnings rose to $113.9 million (97 cents per share) from $99.0 million (81 cents per share) in the previous year [2] - The company reported adjusted EPS of 94 cents, exceeding the consensus of 92 cents [2] - Donaldson raised its fiscal 2026 guidance for adjusted EPS to a range of $3.95-$4.11, compared to the previous range of $3.92-$4.08 and the consensus of $4.01 [2] Stock Performance - Donaldson shares increased by 4.7% to $91.78 on Thursday [3] - Other notable stock performances included UiPath Inc. with a 16.5% increase, Science Applications International Corporation with a 15.8% rise, and Dollar General Corporation with a 9% gain following better-than-expected financial results [5]

Core Insights - ASP Isotopes Inc. has established a new Photonics Chair at the University of Witwatersrand, Johannesburg, through a three-year donation agreement, with Dr. Angela Dudley as the inaugural chair [1][2][3] Company Overview - ASP Isotopes Inc. is focused on developing technologies and processes for isotope production across multiple industries, employing proprietary Aerodynamic Separation Process technology [5][6] - The company aims to produce and commercialize highly enriched isotopes for healthcare and technology, and plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [5][6] Industry Impact - The new Photonics Chair is expected to enhance South Africa's photonics research capabilities, supporting the Structured Light Laboratory's work in advancing photonics applications [2][4] - Photonics is transforming various sectors, including healthcare, telecommunications, manufacturing, security, renewable energy, and quantum computing, by improving medical diagnostics and communication networks [4][5] Research and Development - Dr. Angela Dudley will lead research that translates fundamental photonics research into real-world applications, bringing a distinguished record of research excellence and global collaboration [3][4] - The initiative aligns with South Africa's national quantum strategy, aiming to convert scientific advancements into new economic opportunities [5] Educational Contributions - The establishment of the Photonics Chair is expected to produce a pipeline of skilled talent for ASP Isotopes, supporting the company's growth and innovation in the field [6]